BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 33276704)

  • 1. Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document.
    Jonklaas J; Bianco AC; Cappola AR; Celi FS; Fliers E; Heuer H; McAninch EA; Moeller LC; Nygaard B; Sawka AM; Watt T; Dayan CM
    Thyroid; 2021 Feb; 31(2):156-182. PubMed ID: 33276704
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document.
    Jonklaas J; Bianco AC; Cappola AR; Celi FS; Fliers E; Heuer H; McAninch EA; Moeller LC; Nygaard B; Sawka AM; Watt T; Dayan CM
    Eur Thyroid J; 2021 Mar; 10(1):10-38. PubMed ID: 33777817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary Results of a Double-Blind Randomized Controlled Trial Evaluating the Cardiometabolic Effects of Levothyroxine and Liothyronine Compared to Levothyroxine with Placebo in Athyreotic Low-Risk Thyroid Cancer Patients.
    Biondi B; Pucci M; Pontieri G; Formisano P; Esposito R
    Thyroid; 2023 Dec; 33(12):1402-1413. PubMed ID: 37725587
    [No Abstract]   [Full Text] [Related]  

  • 4. Levothyroxine Monotherapy: What Works Better for the Individual With Hypothyroidism?
    Hennessey JV
    Endocr Pract; 2023 Jul; 29(7):572-580. PubMed ID: 37419564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hypothyroidism with levothyroxine plus liothyronine: a randomized, double-blind, crossover study.
    Kaminski J; Miasaki FY; Paz-Filho G; Graf H; Carvalho GA
    Arch Endocrinol Metab; 2016; 60(6):562-572. PubMed ID: 27982198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized double-blind placebo-controlled trial on levothyroxine and liothyronine combination therapy in totally thyroidectomized subjects: the LEVOLIO study.
    Brigante G; Santi D; Boselli G; Margiotta G; Corleto R; Monzani ML; Craparo A; Locaso M; Sperduti S; Roy N; Casarini L; Trenti T; Tagliavini S; De Santis MC; Roli L; Rochira V; Simoni M
    Eur J Endocrinol; 2024 Jan; 190(1):12-22. PubMed ID: 38124252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Systematic Review of Clinical Practice Guidelines' Recommendations on Levothyroxine Therapy Alone versus Combination Therapy (LT4 plus LT3) for Hypothyroidism.
    Kraut E; Farahani P
    Clin Invest Med; 2015 Dec; 38(6):E305-13. PubMed ID: 26654514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liothyronine use in primary hypothyroidism - current concepts.
    Concepción-Zavaleta MJ; Ildefonso-Najarro SP; Paz-Ibarra JL; Valdivia Fernández-Dávila FR; Deutz Gómez-Condori DC; Rivera-Fabián KE; Herrera-Cabezas RG; Concepción-Urteaga LA
    Endokrynol Pol; 2021; 72(6):650-660. PubMed ID: 34855197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are We Restoring Thyroid Hormone Signaling in Levothyroxine-Treated Patients With Residual Symptoms of Hypothyroidism?
    Casula S; Ettleson MD; Bianco AC
    Endocr Pract; 2023 Jul; 29(7):581-588. PubMed ID: 37419565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Liothyronine Treatment on Quality of Life in Female Hypothyroid Patients With Residual Symptoms on Levothyroxine Therapy: A Randomized Crossover Study.
    Bjerkreim BA; Hammerstad SS; Gulseth HL; Berg TJ; Omdal LJ; Lee-Ødegård S; Eriksen EF
    Front Endocrinol (Lausanne); 2022; 13():816566. PubMed ID: 35273566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal.
    Van Tassell B; Wohlford GF; Linderman JD; Smith S; Yavuz S; Pucino F; Celi FS
    Thyroid; 2019 Oct; 29(10):1371-1379. PubMed ID: 31364488
    [No Abstract]   [Full Text] [Related]  

  • 12. Physician Choice of Hypothyroidism Therapy: Influence of Patient Characteristics.
    Jonklaas J; Tefera E; Shara N
    Thyroid; 2018 Nov; 28(11):1416-1424. PubMed ID: 30289349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial.
    Appelhof BC; Fliers E; Wekking EM; Schene AH; Huyser J; Tijssen JG; Endert E; van Weert HC; Wiersinga WM
    J Clin Endocrinol Metab; 2005 May; 90(5):2666-74. PubMed ID: 15705921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Long-Term Combination LT4 and LT3 Therapy for Improving Hypothyroidism and Overall Quality of Life.
    Tariq A; Wert Y; Cheriyath P; Joshi R
    South Med J; 2018 Jun; 111(6):363-369. PubMed ID: 29863229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liothyronine and Desiccated Thyroid Extract in the Treatment of Hypothyroidism.
    Idrees T; Palmer S; Maciel RMB; Bianco AC
    Thyroid; 2020 Oct; 30(10):1399-1413. PubMed ID: 32279609
    [No Abstract]   [Full Text] [Related]  

  • 16. Heart Failure and Stroke Risks in Users of Liothyronine With or Without Levothyroxine Compared with Levothyroxine Alone: A Propensity Score-Matched Analysis.
    Yi W; Kim BH; Kim M; Kim J; Im M; Ryang S; Kim EH; Jeon YK; Kim SS; Kim IJ
    Thyroid; 2022 Jul; 32(7):764-771. PubMed ID: 35570696
    [No Abstract]   [Full Text] [Related]  

  • 17. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.
    Jonklaas J; Bianco AC; Bauer AJ; Burman KD; Cappola AR; Celi FS; Cooper DS; Kim BW; Peeters RP; Rosenthal MS; Sawka AM;
    Thyroid; 2014 Dec; 24(12):1670-751. PubMed ID: 25266247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial.
    Clyde PW; Harari AE; Getka EJ; Shakir KM
    JAMA; 2003 Dec; 290(22):2952-8. PubMed ID: 14665656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design.
    Premawardhana LD; Taylor PN; Okosieme OE; Adlan MA; Obuobie EK; Dayan CM
    Front Endocrinol (Lausanne); 2023; 14():1282608. PubMed ID: 38034018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Optimal Combination LT4 + LT3 Therapy for Hypothyroidism Based on Residual Thyroid Function.
    DiStefano J; Jonklaas J
    Front Endocrinol (Lausanne); 2019; 10():746. PubMed ID: 31803137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.